Shares of Ocugen (OCGN -5.87%) are falling sharply on Wednesday and were down by 15% as of 12:27 p.m. EST after plunging by as much as 21.2% earlier today. The company did not report any news, but after the stock skyrocketed by about 80% on Tuesday, today's losses could be due to investors taking some profits after yesterday's furious rally.
Why did ocugen stock fall on Tuesday?
Apr 18, 2022 · What happened. Although it had good news to report, Ocugen ( OCGN -5.80% ) nevertheless saw its stock decline by almost 6% on Monday. That news clearly wasn't good enough for investors, who were ...
Is ocugen stock finally showing signs of weakness?
Get the latest Ocugen, Inc. (OCGN) stock news and headlines to help you in your trading and investing decisions.
Should technical traders consider buying ocugen (ocgn) stock?
Jul 09, 2021 · Why Shares of Ocugen Are Dropping Today By Jim Halley - Jul 9, 2021 at 5:11PM Key Points The World Health Organization is reportedly saying a decision on Covaxin should come in four to six weeks....
Does ocugen have the same profit share structure as America?
Apr 19, 2022 · Apr. 18, 2022, 07:25 PM. Although it had good news to report, Ocugen (NASDAQ: OCGN) nevertheless saw its stock decline by almost 6% on Monday. That news clearly wasn't good enough for investors ...
Why is Ocugen stock dropping?
The steep decline came after the company announced that the U.S. Food and Drug Administration (FDA) won't grant Emergency Use Authorization (EUA) for COVID-19 vaccine Covaxin in children ages two to 18.Mar 4, 2022
Will Ocugen stock go back up?
Long-term Ocugen stock forecast 2022-2025 The site predicted that the share price could climb over the next year, to $7.2 by March 2023.Mar 23, 2022
Is Ocugen a good stock to hold?
The consensus among Wall Street research analysts is that investors should "hold" Ocugen stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OCGN, but not buy additional shares or sell existing shares.
Why is Ocugen stock up today?
What happened. Shares of Ocugen ( OCGN -7.07% ) had skyrocketed by 19.1% as of 11:15 a.m. ET on Tuesday. The huge gain came after the company announced that the Food and Drug Administration (FDA) had lifted the clinical hold on its investigational new drug (IND) application for COVID-19 vaccine Covaxin.Feb 22, 2022
Will Ocugen stock go up tomorrow?
Tomorrow's movement Prediction of Ocugen Inc OCGN as on 04 Apr 2022 appears strongly Bullish. This stock started moving upwards as soon as it opened....Munafa value: 65 as on 04 Mon Apr 2022.Upside target3.75Upside target3.47Downside target3.33Downside target3.3Downside target3.185 more rows
Who is making Covaxin?
COVAXIN®, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV).
What will OCGN reach?
The 4 analysts offering 12-month price forecasts for Ocugen Inc have a median target of 7.00, with a high estimate of 15.00 and a low estimate of 4.00. The median estimate represents a +137.69% increase from the last price of 2.95.
Will Bionano Genomics stock go up?
The BioNano Genomics Inc. stock price gained 2.87% on the last trading day (Wednesday, 13th Apr 2022), rising from $2.09 to $2.15. , and has now gained 3 days in a row....Predicted Opening Price for BioNano Genomics Inc. of Thursday, April 14, 2022.Fair opening price April 14, 2022Current price$2.13$2.15 (Overvalued)
2 Popular Robinhood Stocks I Wouldn't Buy With Free Money
Robinhood Markets is the company behind investing platform Robinhood. Particularly popular among younger generations, Robinhood has received a lot of praise because of its efforts to "democratize finance." Considering the stock market remains one of the best wealth generators for the common person, that is not a bad thing.
11 Biotech Stocks Popular On Reddit
In this article, we discuss the 11 biotech stocks popular on Reddit. If you want to skip our detailed analysis of these stocks, go directly to the 5 Biotech Stocks Popular On Reddit. Biotechnology is one of the fields in which Reddit investors take active interest amid an explosive growth potential of the biotech industry. According […]
Ocugen Now Relies Solely on a Continued Covid-19 Crisis
I have written two articles about Ocugen (NASDAQ:OCGN) in the past and I must say that if I had to summarize OCGN stock in two words, they would be irrational exuberance. Source: shutterstock.com/PhotobyTawat As of August 9, 2021, the company has a market valuation of $1.61 billion with zero revenue for 2019 and 2018.
Implied Volatility Surging for Ocugen (OCGN) Stock Options
Investors need to pay close attention to Ocugen (OCGN) stock based on the movements in the options market lately.
Ocugen, Inc. (OCGN) Q2 2021 Earnings Call Transcript
With me today is Ocugen's chairman and CEO, Dr. Shankar Musunuri, who will provide a business update, and our financial officer -- chief financial officer and head of corporate development, Sanjay Subramanian, who will provide a financial update.
Why Ocugen Is Rallying Today
Shares of coronavirus vaccine developer Ocugen (NASDAQ: OCGN) are up 6.74% to $8.00 apiece as of 2:30 p.m. EDT. The company provided business updates in its second-quarter earnings release earlier in the day.
Ocugen's (OCGN) Q2 Earnings Miss Estimates, Stock Down
Ocugen (OCGN) miss earnings estimates in the second quarter of 2021. Stock down.
Key Points
The World Health Organization is reportedly saying a decision on Covaxin should come in four to six weeks.
What happened
Shares of Ocugen ( NASDAQ:OCGN) dropped more than 3% on Friday. The stock opened at $7.46, but by 2:30 p.m., it was down to $7.25. Ocugen's stock is still up more than 295% for the year.
So what
The biggest driver for the move is likely the uncertainty around the company's partnership deal with India pharmaceutical company Bharat Biotech regarding Covaxin, an anti-coronavirus vaccine that is already being administered in India.
Now what
The hope was that Covaxin sales would give Ocugen some much-needed revenue to pursue its other therapies. It appears the company may have to wait a while before that happens. In the meantime, Ocugen has $44.7 million in cash and lost $7 million in the first quarter.